Manuela Mancini
3PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.Manuela Mancini, Sara De Santis, Cecilia Monaldi
|Jan 29, 2020
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis.Manuela Mancini, Sara De Santis, Cecilia Monaldi
|Apr 13, 2017
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.Manuela Mancini, Fausto Castagnetti, Simona Soverini
Pageof 1
